Past Is Prologue: Ethical Issues in Pediatric Psychedelics Research and Treatment
Perspectives in biology and medicine 2023 Gail A. Edelsohn, Dominic Sisti 8 citations
Recent clinical trials of psychedelic drugs aim to treat a range of psychiatric conditions in adults. MDMA and psilocybin administered with psychotherapy have received FDA designation as "breakthrough therapies" for post-traumatic stress disorder (PTSD) and treatment-resistant depression (TRD) respectively. Given the potential benefit for minors burdened with many of the same disorders, calls...
DOI: 10.1353/pbm.2023.0007 (opens in new tab)
Psilocybin
Prologue
Psychotherapist
Informed consent
+1